Developer Merus is continuing to pursue its effort to develop a North Jacksonville business park on land it proposes to buy ...

Nashville’s Rivergate Mall sold, paving the way for a $450 million overhaul. After striking a deal with Metro last year, ...

On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell lung ...

A 122,000-square-foot Columbus building that houses the State Library of Ohio could be demolished under a proposal to ...

Analysts have hailed Merus’ latest data drop in head and neck cancer as meeting investors’ expectations for the bispecific antibody. The slim slice of efficacy data, which Merus presented at the 2024 ...

Development company Merus purchased Nashville's RiverGate Mall Feb. 13 for $33M with plans for a $450M redevelopment.

Phase 3 registrational trials evaluating petosemtamab in combination with pembrolizumab in 1L and petosemtamab monotherapy in 2/3L r/m HNSCC enrolling Petosemtamab in 2L+ r/m HNSCC interim clinical ...

Merus N.V. (NASDAQ:MRUS) shares are trading higher Friday after the company reported promising interim results from its ongoing phase 2 trial evaluating petosemtamab in combination with pembrolizumab ...

Monday - Friday, 6:00 - 7:00 PM ET It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

YLÖJÄRVI, Finland, February 11, 2026--(BUSINESS WIRE)--Merus Power Oyj has signed a battery energy storage deal worth approximately 13 million euros with Neve Oy. The 30 MW/80 MWh facility is designed ...

– Petosemtamab granted Fast Track Designation for the treatment of patients with recurrent or metastatic head & neck squamous cell carcinoma – Phase 3 trial of petosemtamab monotherapy in previously ...